Department of Pharmacology;
Egyptian Drug Authority;
EDA;
formerly NODCAR;
Giza;
Egypt;
Department of Pharmacology and Toxicology;
Faculty of Pharmacy;
Cairo University;
Cairo;
Egypt;
Alzheimer’s disease; autophagy; drug re-positioning; epidermal growth factor receptor; human epidermal growth factor receptor-2; neurodegenerative diseases; neuroinflammation; oxidative stress; tyrosine kinase inhibitors;